Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region

被引:0
|
作者
Tamaskovics, Balint [1 ]
Haussmann, Jan [1 ]
Neuwahl, Judith [1 ]
Jazmati, Danny [1 ]
Plettenberg, Christian [2 ]
Althaus, Laurenz [2 ]
Boelke, Edwin [1 ]
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
机构
[1] Univ Klinikum Dusseldorf, Klin Strahlentherapie & Radioonkol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Hals Nasen Ohrenheilkunde, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P22-12
引用
收藏
页码:S166 / S166
页数:1
相关论文
共 50 条
  • [21] Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma
    Hsieh, Ching-Yun
    Chang, Wei-Chao
    Lin, Ching-Chan
    Chen, Jong-Hang
    Lin, Chen-Yuan
    Liu, Chia-Hua
    Lin, Chen
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5049 - +
  • [22] Metastatic cutaneous squamous cell carcinoma of the head and neck region
    Tavin, E
    Persky, M
    LARYNGOSCOPE, 1996, 106 (02): : 156 - 158
  • [23] Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
    Flanagan, Kevin C.
    Earls, Jon
    Hiken, Jeffrey
    Wellinghoff, Rachel L.
    Ponder, Michelle M.
    Mcleod, Howard L.
    Westra, William H.
    Vavinskaya, Vera
    Sutton, Leisa
    Deichaite, Ida
    Macdonald, Orlan K.
    Welaya, Karim
    Wade, James, III
    Azzi, Georges
    Pippas, Andrew W.
    Slim, Jennifer
    Bank, Bruce
    Sui, Xingwei
    Kossman, Steven E.
    Shenkenberg, Todd D.
    Alexander, Warren L.
    Price, Katharine A.
    Ley, Jessica
    Messina, David N.
    Glasscock, Jarret, I
    Colevas, A. Dimitrios
    Cohen, Ezra E. W.
    Adkins, Douglas
    Duncavage, Eric J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [24] Impact of ECOG performance status on recurrent/metastatic head and neck squamous cell carcinomas treated with anti-PD1 inhibitors.
    Chalker, Cameron
    Wu, Vicky
    Voutsinas, Jenna M.
    Hwang, Victoria
    Baik, Christina S.
    Liao, Jay Justin
    Lee, Sylvia
    Futran, Neal D.
    Houlton, Jeffrey
    Barber, Brittany
    Parvathaneni, Upendra
    Laramore, George E.
    Santana-Davila, Rafael
    Eaton, Keith D.
    Martins, Renato G.
    Rodriguez, Cristina P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma
    Hui, Rongrong
    Liu, Xiulan
    Fan, Zongyu
    Ji, Honghai
    Wei, Dongliang
    Ren, Guoxin
    JOURNAL OF CANCER, 2024, 15 (06): : 1668 - 1674
  • [26] NEMVALEUKIN ALFA, A NOVEL ENGINEERED IL-2 CYTOKINE, IN COMBINATION WITH THE ANTI-PD-1 ANTIBODY PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (ION-01 STUDY)
    Gastman, Brian
    Cheever, Mac
    Fling, Steven
    Perez, Cesar
    Patel, Manish
    Geiger, Jessica
    Li, Zujun
    Posner, Marshall
    Steuer, Conor
    D'Amico, Leonard
    Kask, Angela Shaulov
    Du, Yangchun
    Matthies, Derek
    Huh, Sung Jin
    Wang, Yan
    Graham, Julie
    Chow, Laura
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A462 - A462
  • [27] RADIOTHERAPY FOR POSTOPERATIVE RECURRENT SQUAMOUS-CELL CARCINOMA IN HEAD AND NECK
    DEUTSCH, M
    LEEN, R
    PARSONS, JA
    MERCADO, R
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1973, 98 (05) : 316 - 318
  • [28] Necroptosis is Related to Anti-PD-1 Treatment Response and Influences the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
    Wang, Qiwei
    Wang, Fang
    Zhao, Yinan
    Tan, Guolin
    FRONTIERS IN GENETICS, 2022, 13
  • [29] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, Alice
    Uguen, Arnaud
    Lemasson, Gilles
    Conan-Charlet, Virginie
    Pradier, Olivier
    Lucia, Francois
    Schick, Ulrike
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 343 - 351
  • [30] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Delafoy, A.
    Uguen, A.
    Key, S.
    Lucia, F.
    Lemasson, G.
    Abgral, R.
    Dissaux, G.
    Pradier, O.
    Schick, U.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S627 - S628